Comment je traite...un patient atteint de mycosis fongoide.

Pierard, Claudine; Pierard, Gérald

Download

Article (Scientific journals)

Comment je traite...un patient atteint de mycosis fongoide.

Pierard, Claudine; Pierard, Gérald

2006 • In Revue Médicale de Liège, 61 (11), p. 740-6

Peer reviewed

Permalink
https://hdl.handle.net/2268/6337

PubMed
17191739

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

COMMENT...MYCOSIS.pdf

Publisher postprint (1.05 MB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Humans; Mycosis Fungoides/diagnosis/therapy; Neoplasm Staging; Prognosis; Skin Neoplasms/diagnosis/therapy

Abstract :

[en] Primary lymphomas of the skin exhibit singular clinical, histological and prognostic features that are not shared by lymphomas originating from the lymphoid tissues. This review is an update of the current concepts about the diagnosis and treatment of mycosis fungoides, the most frequent entity among the primary cutaneous lymphomas.

Disciplines :

Dermatology

Author, co-author :

Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

French

Title :

Comment je traite...un patient atteint de mycosis fongoide.

Alternative titles :

[en] How I treat...a patient presenting with mycosis fungoides.

Publication date :

2006

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

740-6

Peer reviewed :

Peer reviewed

Available on ORBi :

since 16 February 2009

Statistics

Number of views

183 (1 by ULiège)

Number of downloads

932 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Willemze R, Jaffe ES, Burg G, et al. - WHO-EORTC classification for cutaneous lymphomas. Blood, 2005, 105, 3768-3785.
Nikkeis AF, Quatresooz P, Delvenne P, et al. - Mycosis fungoides progression and chronic solvent exposure. Dermatology, 2004, 208, 171-172.
Grob JJ. - Epidémiologie du mycosis fongoïde. Ann Dermatol Venereol, 2005, 132, S11-S12.
Willemze R, Kerl H, Sterry W, et al. - EORTC classification for primary cutaneous lymphomas : a proposal from the cutaneous study group of the european organization for research and treatment of cancer. Blood, 1997, 90, 354-371.
Zackhei H, Amin S, Kashasni-Sabat M, McMillan A. - Prognosis in cutaneous T-cell lymphoma by skin stage : long-term survival in 489 patients. J Am Acad Dermatol, 1999, 40, 418-425.
Van Doom R, Van Haselen CW, Van Voorst PC, et al. - Mycosis fongoides : disease evolution and prognosis of 309 Dutch patients. Arch Dermatol, 2000, 136, 504-510.
Kim YH, Liu HL, Mraz-Gernhard S, et al. - Long-term outcome of 525 patients with mycosis fongoides and Sezary syndrome : clinical pronostic factors and risk for disease progression. Arch Dermatol, 2003, 139, 857-866.
Piérard GE, Piérard-Franchimont C, Hermanns-Lê T, et al. - Factor XIIIa positive dendritic cells in mycosis fongoides. Cancer J, 1992, 5, 226-229.
Fivenson DP, Nickoloff BJ. - Distinctive dendritic cell subsets expressing factor XIIIa, CD1a, CD1b and CD1c in mycosis fungoides and psoriasis. J Cutan Pathol , 1995, 22, 223-228.
Piérard GE, Franchimont C, Le T, et al. - Proliferation rate of cutaneous T cell lymphomas in the skin. Relationship with histological pattern and cytology. In : Lymphoproliferative diseases of the skin, Goos M, Christophers E (eds) Springer Verlag, Berlin, 1982, 65-70.
Piérard GE, Piérard-Franchimont C. - Patt ern of distribution and intensity of blastogenesis as clues for distinguishing pseudolymphomas from lymphomas. Br J Dermatol, 1983, 109, 253-259.
Cordel N, Lenormand B, Courville P, et al. - Usefulness of cutaneous T cell clonality analysis for the diagnosis of cutaneous T cell lymphoma in patients with erythroderma. Arch Pathol Lab Med, 2005, 129, 372-376.
Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. - Joint British association of dermatologists and UK cutaneous lymphoma group guidelines for the management of primary cutaneous T cell lymphomas. Br J Dermatol, 2003, 149, 1095-1107.
de Quatrebarbes J, Esteve F, Bagot M, et al. - Treatment of early stage mycosis fongoides with twice-daily applications of mechlorethamine and topical corticosteroids : a prospective study. Arch Dermatol, 2005, 141, 1117-1120.
Jones GW, Kacinski BM, Wilson LD, et al. - Total skin electron radiation in the management of mycosis fongoides : concensus of the European Organisation of Research and Treatment of Cancer (EORTC) cutaneous lymphoma project group. J Am Acad Dermatol, 2002, 47, 364-370.
Duvic M, Martin AG, Kim Y, et al. - Worldwide bexarotene study group. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T cell lymphoma. Arch Dermatol, 2001, 137, 581-593.
Duvic M, Hymes K, Heald P, et al. - Bexarotene worldwide study group. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T cell lymphoma : multinational phase II-III trial results. J Clin Oncol, 2001, 19, 2456-2471.
McGinnis KS, Shapiro M, Vittorio CC, et al. - Psoralen plus long-wave UVA (PUVA) and bexarotene therapy : an effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T cell lymphoma. Arch Dermatol, 2003, 139, 881-775.
McGinnis KS, Junkins-Hopkins JM, Crawford G, et al. - Low-dose oral bexarotene in combination with low-dose intereferon alfa in the treatment of cutaneous T-cell lymphoma : clinical synergism and possible immunologic mechanisms. J Am Acad Dermatol, 2004, 50, 375-379.
Dreno B. - Interferon et lymphome cutané T épidermotrope. Ann Dermatol Venereol, 2005, 132, S37-S30.
Apisarnthanarax N, Talpur R, Duvic M. - Treatment of cutaneous T cell lymphomas. Current status and future directions. Am J Clin Dermatol, 2002, 3, 193-215.
Dereure O. - Traitements systémiques des lymphomes cutanés T épidermotropes (hors interferon et photophérèse). Ann Dermatol Venereol, 2005, 132, S31-S36.
Abou-Samra T, Viraben R, Dincan M. - Thérapeutiques immunomodulatrices innovantes en cours d'évaluation. Ann Dermatol Venereol, 2005, 132, S39-S41.